Heart Health & Lipid Calculator (2026 Standards)
Assess your cardiovascular health using the 2026 PREVENT™ equations and advanced lipid ratios. This tool calculates your 10-year and 30-year ASCVD risk while providing personalized targets for LDL-C, Non-HDL-C, and ApoB based on the latest clinical guidelines.
Your Assessment Results
LDL-C vs Target
10-Year Risk %
Cholesterol Ratio Calculator: Understanding Your 2026 Heart Health Risk
In 2026, managing cardiovascular health has evolved beyond simple "Total Cholesterol" numbers. Modern cardiology now focuses on specific atherogenic particles and the PREVENT™ (Predicting Risk of cardiovascular Disease EVENTs) equations developed by the American Heart Association. This calculator integrates these new standards to provide a comprehensive outlook on your heart health.
Why Ratios Matter More Than Single Values
While having a high LDL (Low-Density Lipoprotein) is a known risk factor, ratios such as the TC/HDL ratio and TG/HDL ratio offer deeper insights into metabolic health and insulin resistance. A high Triglyceride-to-HDL ratio often suggests the presence of small, dense LDL particles, which are more prone to causing arterial plaque than larger particles.
The 2026 Risk Categories (PREVENT™ Model)
The PREVENT equation is the gold standard in 2026, replacing the older Pooled Cohort Equations. It categorizes risk into four distinct tiers:
- Low Risk (< 3%): Focus on maintaining a healthy lifestyle (Life’s Essential 8).
- Borderline Risk (3% to < 5%): Consider Coronary Artery Calcium (CAC) scoring to refine risk.
- Intermediate Risk (5% to < 10%): Discussion of statin therapy is usually recommended.
- High Risk (≥ 10%): Intensive lipid-lowering therapy is typically required to prevent events.
New Key Markers: Non-HDL and ApoB
Expert guidelines now emphasize Non-HDL Cholesterol (Total Cholesterol minus HDL) as a superior marker because it accounts for all "bad" cholesterol types, including VLDL and IDL. Furthermore, Apolipoprotein B (ApoB) measures the actual number of atherogenic particles. If your LDL is at goal but your ApoB remains high, you still have significant residual risk.
Actionable Steps for Heart Protection
If your results fall into the intermediate or high-risk categories, the 2026 protocols suggest a multi-layered approach. This includes high-intensity statins, and if targets (like LDL < 55 mg/dL for very high risk) are not met, the addition of Ezetimibe or PCSK9 inhibitors. Lifestyle remains the foundation—focusing on fiber intake, reducing saturated fats, and maintaining a healthy BMI.